| Table V.1: States That Reported Participating in FDA-Sponsored Activities Related to Drug Compounding, and How These States Rated the Helpfulness of Each Activity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Food and Drug Administration (FDA) sponsored activity | Number of states that reported participating in activity (%) | How states that reported participating in FDA-sponsored activities rated the helpfulness of each activity | ||||||||
| Yes | No | Don't know | No response | Very helpful |
Moderately helpful |
Slightly helpful |
Not at all helpful |
Don’t know | No response | |
| FDA's March 2014 Intergovernmental Working Meeting on Pharmacy Compounding | 41 (82) | 2 (4) | 4 (8) | 3 (6) | 15 | 18 | 4 | 0 | 2 | 2 |
| FDA's March 2015 Intergovernmental Working Meeting on Pharmacy Compounding | 37 (74) | 7 (14) | 4 (8) | 2 (4) | 11 | 17 | 5 | 0 | 3 | 1 |
| FDA's November 2015 Intergovernmental Working Meeting on Pharmacy Compounding | 35 (70) | 11 (22) | 1 (2) | 3 (6) | 13 | 12 | 5 | 1 | 2 | 2 |
| FDA's Pharmacy Compounding Advisory Committee meeting, February 2015a | 8 (16) | 31 (62) | 9 (18) | 2 (4) | 3 | 3 | 2 | 0 | 0 | 0 |
| FDA's Pharmacy Compounding Advisory Committee meeting, June 2015a | 7 (14) | 34 (68) | 5 (10) | 4 (8) | 2 | 3 | 2 | 0 | 0 | 0 |
| Source: GAO survey of state pharmacy regulatory bodies, survey question 27. | GAO-17-363SP |
| Notes: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey. |
| aThe Drug Quality and Security Act, enacted in November 2013, required FDA to convene and consult with a Pharmacy Compounding Advisory Committee before issuing certain regulations. |